Limacorporate And Orthofix Medical Announce Partnership


Hitesh

Orthofix Medical Inc., a global medical device company and orthopaedics focused on the spine, and Limacorporate SpA, a global orthopaedic company focused on digital innovation and patient-friendly hardware, today announced a licence agreement for the US market to provide a novel solution for patients with the difficult condition of chronic […]

Telix Pharmaceuticals announces that ZIRCON Phase III Kidney Cancer Imaging Study Completes Enrolment


Hitesh

The investigational renal (kidney) cancer imaging drug TLX250-CDx from Telix Pharmaceuticals Limited has dosed the final patient and finished enrollment in the Phase III pivotal research ZIRCON (Zirconium in Renal Cancer Oncology, NCT03849118) (89Zr-DFO-girentuximab). To present, 300 patients have received doses as part of this international study, exceeding the 252 […]

Marshfield Clinic Health System Partners with Force Therapeutics to Improve Orthopedic Care


Hitesh

Force Therapeutics announced that Marshfield Clinic Health System (MCHS), an integrated delivery network in Wisconsin, has selected its digital care management platform to improve access to care, reduce cost and quality variation, and increase patient-reported outcomes collection. Force’s provider-driven platform uses customized care paths and virtual education and physical therapy […]

CHA Health Systems Partners With Ceras Health to Improve Real-Time Care Coordination and Health Outcomes for Patients


Hitesh

CHA Health Systems (CHS), a global leader in healthcare and biotechnology, today announced a partnership with digital healthcare services company Ceras Health (Ceras) to use its breakthrough digital transitions of care solutions, to drive improved health outcomes and care coordination for the health system’s Medicare and other vulnerable patient populations. […]

JW Therapeutics Announces Trial of JWATM204 in Liver Cancer Patients


Hitesh

JW Therapeutics, an independent and innovative biotechnology company specializing in the development, manufacture and commercialization of cellular immunotherapy, announced the start of a phase I clinical trial of JWATM204 in patients with hepatocellular carcinoma (HCC) at an advanced stage. Primary liver cancer, also known as liver carcinoma, is one of […]

Radiometer and Etiometry Announce Partnership to Enhance Neonatal Intensive Care Clinical Workflows and Patient Outcomes


Hitesh

Etiometry, a leader in clinical decision-support software for critical care, and Radiometer, a leading medical device company specializing in acute care testing solutions, today announced a new collaboration to enhance the clinical workflows in Neonatal Intensive Care Units (NICU). The partnership pairs Etiometry’s platform to create a holistic view of […]